# Correction: Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence

**Authors:** Anikó Kovács, Leif Klint, Barbro Linderholm, Toshima Z. Parris

PMC · DOI: 10.1007/s10549-025-07828-x · Breast Cancer Research and Treatment · 2025-09-26

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** breast carcinoma (MESH:D001943), metastases (MESH:D009362)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12583303/full.md

---
Source: https://tomesphere.com/paper/PMC12583303